about
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granul...
Read More
5.52
0.00
(0.00%)
1.0M
XNAS Volume
XNAS 17 Jul, 2026 4:16 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Savara Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..